AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05549401 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-828, D097, D337
Description: QD, PQ
Study NCT05961358 — intervention group
Intervention type: PROCEDURE
Intervention: snapshots or videos of monitor
Description: The mobile device（a phone）was used to obtain the screen image of the monitor, and the arterial blood pressure waveform is extracted by image processing technology.
Study NCT05961358 — intervention group
Intervention type: PROCEDURE
Intervention: Pressure transducer
Description: Arterial catheter were connected to conventional pressure transducers and Flotrac-Vigileo transducers.
Study NCT05900284 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin low dose
Description: If randomized to the 500 mg. Metformin arm, a tablet will be administered orally to the study participant twice a day for the initial five days starting on the date of study enrollment. Clinical research coordinators will collect blood and urine samples from study participants in both treatment arms. The blood will be collected at Baseline, Day 1 thru 7, and at hospital discharge or Day 30, whichever occurs first. On Day 2 and Day 5, the blood will be collected at hour-based intervals of 0.5h, 1h, 2h, 4h, 8h, 12h for a pharmacokinetic profile and delivered to the University of Pittsburgh Medical Center Clinical Laboratory for analysis. The remaining blood collection tubes will be delivered to the Clinical Research Biospecimen Core laboratory to be processed, separated into microtubes, and stored at -80°. Urine samples will be collected at Baseline, Day 1, 3, and 5. The urine will be processed, separated into microtubes, and frozen at -80°.
Study NCT05900284 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin high dose
Description: If randomized to the 1000 mg. Metformin arm, a tablet will be administered orally to the study participant twice a day for the initial five days starting on the date of study enrollment. Clinical research coordinators will collect blood and urine samples from study participants in both treatment arms. The blood will be collected at Baseline, Day 1 thru 7, and at hospital discharge or Day 30, whichever occurs first. On Day 2 and Day 5, the blood will be collected at hour-based intervals of 0.5h, 1h, 2h, 4h, 8h, 12h for a pharmacokinetic profile and delivered to the University of Pittsburgh Medical Center Clinical Laboratory for analysis. The remaining blood collection tubes will be delivered to the Clinical Research Biospecimen Core laboratory to be processed, separated into microtubes, and stored at -80°. Urine samples will be collected at Baseline, Day 1, 3, and 5. The urine will be processed, separated into microtubes, and frozen at -80°.
Study NCT05900284 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: If randomized to the Placebo arm, a tablet will be administered orally to the study participant twice a day for the initial five days starting on the date of study enrollment. Clinical research coordinators will collect blood and urine samples from study participants in both treatment arms. The blood will be collected at Baseline, Day 1 thru 7, and at hospital discharge or Day 30, whichever occurs first. On Day 2 and Day 5, the blood will be collected at hour-based intervals of 0.5h, 1h, 2h, 4h, 8h, 12h for a pharmacokinetic profile and delivered to the University of Pittsburgh Medical Center Clinical Laboratory for analysis. The remaining blood collection tubes will be delivered to the Clinical Research Biospecimen Core laboratory to be processed, separated into microtubes, and stored at -80°. Urine samples will be collected at Baseline, Day 1, 3, and 5. The urine will be processed, separated into microtubes, and frozen at -80°.
Study NCT05550116 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Giomer
Description: fluoride-releasing coating material containing surface reaction-type pre-reacted glass-ionomer (S-PRG) fillers
Study NCT05550116 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Giomer
Description: fluoride-releasing coating material containing surface reaction-type pre-reacted glass-ionomer (S-PRG) fillers
Study NCT05550116 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Two composite resin sealants
Description: Unfilled composite resin sealants
Study NCT05550116 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Two composite resin sealants
Description: Unfilled composite resin sealants
Study NCT06280703 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3938577
Description: Administered Intravenously (IV)
Study NCT06280703 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered Intravenously (IV)
Study NCT06280703 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin Degludec
Description: Administered Intravenously (IV)
Study NCT06280703 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin Lispro
Description: Administered Intravenously (IV)
Study NCT06280703 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin Lispro
Description: Administered Intravenously (IV)
Study NCT05201573 — intervention group
Intervention type: OTHER
Intervention: Observational
Description: This is an observational study of long term follow up data for patients who previously received the DIAM implant
Study NCT05471960 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Natural progression over time
Description: Each subject will attend eight testing sessions (MRI scanning, two TMS-motor test visits, two TMS-prefrontal test visits, motor assessments, neuropsychological testing, and overnight sleep testing (polysomnography - PSG).
Study NCT05334498 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motor dual-task gait training
Description: Patients were instructed to walk either on treadmill or on the land. During walk; patients were instructed to perform five tasks. The patients performed tossing and catching the ball, rehanging loops on hoops, buttoning and unbuttoning the shirts, holding the cup in water without the spilling and receiving with returning the water. Each activity were performed for three minute and 15 minutes were provided for performing all the tasks
Study NCT05334498 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cognitive dual-task gait training
Description: Patients were instructed to walk either on treadmill or on the land. During walk; patients were instructed to perform five tasks. The patients performed sharp coloring, subtraction, counting, verbal analogical reasoning and backward spelling. Each activity were performed for three minute and 15 minutes were provided for performing all the tasks
Study NCT06109792 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: implant supported mandibular overdenture
Description: In this crossover study, the patients received overdentures with two successive different pick-up techniques for the locator retentive caps; each technique was evaluated for patient satisfaction with blue and pink retentive inserts.
Study NCT04701151 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bacillus Calmette Guerin
Description: The same dose of the drug will be given in both arms but the dwell-time will be adjusted for the subjects in the intervention arm according to the grading of side effects given by the study algorithm.
Study NCT04701151 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bacillus Calmette Guerin
Description: The same dose of the drug will be given in both arms but the dwell-time will be adjusted for the subjects in the intervention arm according to the grading of side effects given by the study algorithm.
Study NCT05563103 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Daily acute intermittent hypoxia
Description: Each participant will be exposed to 8 sessions of daily acute intermittent hypoxia via air generators over the span of two weeks. The generator will fill reservoir bags attached to a non-rebreathing facemask. Each session will consist of 15 episodes which include intervals of 1.5 minute hypoxia (FIO2=0.10±0.02, i.e. 10% O2) and 1 minute normoxia (FIO2=0.21±0.02).
Study NCT05563103 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Daily acute intermittent hypoxia
Description: Each participant will be exposed to 8 sessions of daily acute intermittent hypoxia via air generators over the span of two weeks. The generator will fill reservoir bags attached to a non-rebreathing facemask. Each session will consist of 15 episodes which include intervals of 1.5 minute hypoxia (FIO2=0.10±0.02, i.e. 10% O2) and 1 minute normoxia (FIO2=0.21±0.02).
Study NCT05563103 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Room air (SHAM)
Description: Each participant will be exposed to 8 sessions of daily room air via air generators over the span of two weeks. The generator will fill reservoir bags attached to a non-rebreathing facemask. Each session will consist of 15 episodes of 1.5 minute normoxia (FIO2=0.21±0.02).
Study NCT05563103 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Walking + tSTIM
Description: Individuals will participate in 45 minutes of gait training while having transcutaneous spinal cord stimulation. Stimulation intensity will be 80% involuntary motor threshold.
Study NCT05563103 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Walking + tSTIM
Description: Individuals will participate in 45 minutes of gait training while having transcutaneous spinal cord stimulation. Stimulation intensity will be 80% involuntary motor threshold.
Study NCT05563103 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Walking + Sham transcutaneous spinal stimulation (tSHAM)
Description: Individuals will participate in 45 minutes of gait training while having SHAM transcutaneous spinal cord stimulation. The stimulation will briefly increase to 80% involuntary motor threshold and then brought down to 0 within 30 seconds.
Study NCT05042336 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: camrelizumab/lenvatinib combined with TACE
Description: Lenvatinib 4mg qd body weight≤60,8mg；body weight>60,12mg~Camrelizumab 200mg q2w/q3w
Study NCT04944602 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SYN008
Description: injection of 300 mg
Study NCT04944602 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Omalizumab for injection
Description: injection of 300 mg
Study NCT05349903 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rice flour
Description: Rice flour made into rice porridge will be tested for postprandial glycemic response, gut hormone levels, gastric emptying rate, appetitive response, and fermentability.
Study NCT05349903 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Alternanoligosaccharide 15
Description: Alternanoligosaccharide 15 incorporated into rice porridge will be tested for postprandial glycemic response, gut hormone levels, gastric emptying rate, appetitive response, and fermentability.
Study NCT05349903 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inulin
Description: Inulin incorporated into rice porridge will be tested for postprandial glycemic response, gut hormone levels, gastric emptying rate, appetitive response, and fermentability.
Study NCT05349903 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Waxy potato starch
Description: Retrograded waxy potato starch made into porridge meal will be tested for postprandial glycemic response, gut hormone levels, gastric emptying rate, appetitive response, and fermentability.
Study NCT05349903 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Waxy potato starch + epigallocatechin gallate (EGCG)
Description: A combination of retrograded waxy potato starch and EGCG made into porridge meal will be tested for postprandial glycemic response, gut hormone levels, gastric emptying rate, appetitive response, and fermentability.
Study NCT05349903 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chickpea flour + epigallocatechin gallate (EGCG)
Description: A combination of chickpea flour and EGCG made into porridge meal will be tested for postprandial glycemic response, gut hormone levels, gastric emptying rate, appetitive response, and fermentability.
Study NCT05317156 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cold vapor
Description: Before surgery, the socio-demographic data of the patients will be recorded. After surgery, patients will be evaluated in the recovery room for their suitability to participate in the study with the Ramsay sedation scale and the Modified Aldrete Scale. Cold vapor will be applied to the patients for 15 minutes in the recovery room during the postoperative period. The parameters to be set on the device for the cold vapor to be applied to the patients in the early postoperative period will be vapor intensity level 5, air blowing intensity 5, heater intensity 1 (+10C), and timer 15 minutes. The patients will be evaluated by the researchers in terms of sore throat, cough, hoarseness, and dysphagia before and 15 minutes after the cold vapor application in the recovery room and at the 6th,12th, and 24th hours after the cold vapor application in the postoperative service. In addition, the comfort levels of the patients will be evaluated at the 24th postoperative hour.
Study NCT05047367 — intervention group
Intervention type: BEHAVIORAL
Intervention: cross-sectional survey study
Description: Beck Depression Scale, Beck Anxiety Scale for psychological evaluation, Visual Analogue Scale and PainDETECT Questionnaire for pain, Pittsburgh Sleep Quality Scale and Epworth Sleepiness Scale for sleep quality
Study NCT05968001 — intervention group
Intervention type: DRUG
Intervention: Obinutuzumab
Description: obinutuzumab (G)-contained regimens, including GB, G-CHOP, and G-CVP.
Study NCT04911790 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Experimental Group
Description: SARS-CoV-2 Inactivated Vaccine 600SU inactivated virus in 0·5 mL of aluminiumhydroxide solution per injection
Study NCT05485168 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sequential Variety
Description: 3 different foods served in 3 successive courses
Study NCT05485168 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Single-Food
Description: 1 food served in 3 successive courses
Study NCT05485168 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Small Portion
Description: Small meal portion size
Study NCT05485168 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Large Portion
Description: Large meal portion size
Study NCT05126381 — intervention group
Intervention type: BEHAVIORAL
Intervention: Smoking
Description: The Study contains patients who are allowed to smoke
Study NCT05126381 — intervention group
Intervention type: BEHAVIORAL
Intervention: non-somking
Description: The Study contains patients who are not allowed to smoke
Study NCT04995978 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pioglitazone 30 mg
Description: Subjects will self-administer a 30 mg pioglitazone oral tablet daily for 6 months.~For patient taking a diabetic regimen of gemfibrozil, the dose will be 15 mg daily.
Study NCT04995978 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo tablet
Description: Subjects will self-administer an oral placebo tablet containing cellulose daily for 6 months.
Study NCT05753774 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: FMT
Description: FMT is a technique in which intestinal microbiota are transferred from a healthy screened donor to a patient, with the goal being to introduce or restore a stable microbial community in the gut. FMT was given 1-3courses, 3-6 times per courses
Study NCT05753774 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Conventional drugs
Description: Conventional drugs include probiotics and omeprazole, and cyproheptadine and moxapride
Study NCT04951050 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Rapamycin target eluting stent
Description: Rapamycin target eluting stent
Study NCT05170555 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 68Ga-PSMA
Description: Intravenous injection of one dosage of 74-148 MBq (2-4 mCi) 68Ga-PSMA. Tracer doses of 68Ga- PSMA will be used to image lesions of Renal Cell Carcinoma by PET/CT.
Study NCT05170555 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 1.85GBq (50 mCi) of 177Lu-EB-PSMA-617
Description: Patients were intravenous injected with the dose about 1.85GBq (50 mCi) of 177Lu-EB-PSMA-617 every 8 weeks (±1 week) for a maximum of 3 cycles.
Study NCT05429281 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pilates-based Core Strengthening Exercises
Description: The PsCS group performed eight Pilates exercises over 45 minutes, three times per week for 12 successive weeks. The training was conducted under the supervision of a physical therapist who had more than 5 years of experience in Pilates.
Study NCT05429281 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Plyometric-based Muscle Loading Exercises
Description: The PlyoML group performed 10 plyometric exercises over 45 minutes, three times per week for 12 successive weeks. The training was conducted under the close supervision of a licensed pediatric physical therapist. The safety and performance guidelines, defined by the American Academy of Pediatrics and the US National Strength and Conditioning Association, were considered during training.
Study NCT05429281 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Combined Pilates and Plyometrics
Description: The combined training group performed the same exercises as the PsCS and PlyoML groups, although with half the number of sets/repetitions over 45 minutes, three times per week for 12 successive weeks. The PsCS and PlyoML were executed within the same session, with a 10-to-15-minute rest interval. The training was conducted under the close supervision of a licensed pediatric physical therapist. The safety and performance guidelines, defined by the American Academy of Pediatrics and the US National Strength and Conditioning Association, were considered during training.
Study NCT04984018 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: chidamide + camrelizumab
Description: Pts received 200 mg camrelizumab intravenously every 2 weeks and Chidamide 30mg orally twice (biw) per week for 4 consecutive weeks every 6 weeks until disease progression, unacceptable adverse events (AEs) or withdrawal of consent.
Study NCT05291143 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Short videos on blood pressure monitoring
Description: Short videos on blood pressure monitoring
Study NCT04777630 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: None, neuroimaging
Description: Observation only to observe differences in neuroimaging
Study NCT05624177 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Streptococcus salivarius M18 probiotic 1 billion colony forming units chewing gum (chew 5 minutes)
Description: Probiotic Streptococcus salivarius M18 products are commercially available in traditional formats such as a chewable tablet (lozenge) for local delivery to the oral cavity to provide health benefits. In this study, a chewing gum formulation will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.
Study NCT05624177 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Streptococcus salivarius M18 probiotic 1 billion colony forming units chewing gum (chew 10 minutes)
Description: Probiotic Streptococcus salivarius M18 products are commercially available in traditional formats such as a chewable tablet (lozenge) for local delivery to the oral cavity to provide health benefits. In this study, a chewing gum formulation will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.
Study NCT06065462 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dostarlimab
Description: Given by vein (IV)
Study NCT06065462 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LB-100
Description: GIven by vein (IV)
Study NCT06381089 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Robotic Rehabilitation
Description: Lokomat is an exoskeleton type robotic walking device that can support both extremities symmetrically.
Study NCT06381089 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous Auricular Vagal Nerve Stimulation
Description: Vagus nerve stimulation is defined as any technique that stimulates the vagus nerve in our body.
Study NCT06144216 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CLOE Outreach Intervention
Description: The CLOE outreach intervention is a community-led, strengths-based, and trauma-informed program to support self-identifying women and youth who experience interpersonal and structural gender-based violence. Outreach services are designed to mitigate the effects of gender-based violence, build trusting relationships with service providers, and improve safety, well-being and engagement with health and social care.
Study NCT05356520 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopy Ivor-lewis
Description: Endoscopy Ivor-lewis
Study NCT05356520 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic transabdominal enlarged gastrectomy
Description: Laparoscopic transabdominal enlarged gastrectomy
Study NCT04224779 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Biological collection
Description: The biological collection will include samples of blood samples collected at different times but also tumoral biopsy before the surgery.
Study NCT04208516 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Continuous Erector Spinae Plane Nerve Block
Description: To be administered to subjects in the active comparator group receiving primary unilateral thoracic surgery.